ARCHIVES

ASCO Backs Central IRB For Cancer Trials, Stiffens Conflict-of-Interest Policies

This article is from The Cancer Letter archive.

Vol. 29 No. 18 | May 2, 2003

Download PDF Visit The Full Archive

Related Articles

Anastrozole Better Than Tamoxifen For HR+ Postmenopausal Breast Cancer, Study Finds

May 27, 2005

ASCO Conquer Cancer Foundation Awards $6 Million To Researchers

April 22, 2011

CTEP Drafts FDA Approval Guidelines

March 4, 1988

In Brief: FASEB Letter urges Support Of NIH, NSF; Kansas Recruits Experts From Washington State

July 30, 1993

NIH Modifies IRG voting Procedure In Success Rate Switch

August 30, 1991

Funding Opportunity: DOD Offering 10.5 Million For Lung Cancer Research

May 30, 2014